AstraZeneca’s MedImmune in licensing agreement with Omnis Pharmaceuticals
The agreement will allow MedImmune to combine key agents from its investigational immunotherapy portfolio with Omnis’ lead…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.